Singapore markets close in 31 minutes

Keros Therapeutics, Inc. (KROS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
57.60-0.64 (-1.10%)
At close: 04:00PM EDT
57.60 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
234
151
0
20,100
0
Operating expenses
Research development
142,425
135,258
87,265
55,143
33,860
Selling general and administrative
37,364
34,834
27,525
21,330
12,797
Total operating expenses
177,389
167,692
107,709
76,473
44,197
Operating income or loss
-177,155
-167,541
-107,709
-56,373
-44,197
Interest expense
-
0
1
4
6
Total other income/expenses net
16,853
14,549
3,031
-356
-1,330
Income before tax
-160,302
-152,992
-104,679
-56,733
-45,533
Income tax expense
-
0
0
2,011
-172
Income from continuing operations
-160,302
-152,992
-104,679
-58,744
-45,361
Net income
-160,302
-152,992
-104,679
-58,744
-45,361
Net income available to common shareholders
-160,302
-152,992
-104,679
-58,744
-45,361
Basic EPS
-4.96
-5.20
-4.15
-2.52
-2.93
Diluted EPS
-4.96
-5.20
-4.15
-2.52
-2.93
Basic average shares
28,751
29,447
25,241
23,334
15,506
Diluted average shares
28,751
29,447
25,241
23,334
15,506